Press Releases
Company News
View Summary Medivation Secures $100 Million Committed Equity Financing Facility
Sep 10, 2007
PDF 8.8 KB Add to Briefcase
View Summary Medivation Announces Treatment of First Patient in Phase 2 Trial of Dimebon(TM) in Huntington's Disease
Jul 30, 2007
PDF 10.9 KB Add to Briefcase
View Summary Medivation Announces Treatment of First Patient in Phase 1-2 Clinical Trial of MDV3100 in Hormone-Refractory Prostate Cancer
Jul 25, 2007
PDF 11.4 KB Add to Briefcase
View Summary Medivation Added to Russell 2000 Index
Jul 11, 2007
PDF 8.4 KB Add to Briefcase
View Summary Medivation Names Sarvajit Chakravarty, Ph.D. Vice President of Medicinal Chemistry
Jul 9, 2007
PDF 8.7 KB Add to Briefcase
View Summary Medivation's Dimebon(TM) Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimer's Disease Trial After One Year of Therapy
Jun 11, 2007
PDF 15.4 KB Add to Briefcase
View Summary Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon(TM) Alzheimer's Disease Study
Jun 5, 2007
PDF 10.3 KB Add to Briefcase
View Summary Medivation Announces Presentation of New Subset Analyses From Dimebon(TM) Phase 2 Alzheimer's Disease Trial at American Academy of Neurology Annual Meeting
May 3, 2007
PDF 14.3 KB Add to Briefcase
View Summary Medivation Announces Upcoming Conference Participation
May 3, 2007
PDF 8.0 KB Add to Briefcase
View Summary Medivation Announces First U.S. Presentation of Data From Dimebon(TM) Phase 2 Alzheimer's Disease Trial at American Academy of Neurology Annual Meeting
Apr 24, 2007
PDF 10.9 KB Add to Briefcase
View Summary Medivation CEO to Present at Leerink Swann & Company's Roundtable Conference on Alzheimer's Disease
Mar 27, 2007
PDF 10.6 KB Add to Briefcase
View Summary Medivation Common Stock Begins Trading on Nasdaq Global Market Under the Symbol 'MDVN'
Mar 20, 2007
PDF 9.7 KB Add to Briefcase
View Summary Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Disease Conference
Mar 19, 2007
PDF 12.9 KB Add to Briefcase
View Summary Medivation Common Stock Approved for Listing on the Nasdaq Global Market
Mar 8, 2007
PDF 9.8 KB Add to Briefcase
View Summary Medivation to Present at Cowen and Company's 27th Annual Healthcare Conference
Mar 5, 2007
PDF 10.3 KB Add to Briefcase
View Summary Medivation's MDV3100 Shown to Be Effective in a Preclinical Model of Hormone-Refractory Prostate Cancer
Feb 26, 2007
PDF 12.1 KB Add to Briefcase
View Summary Preclinical Efficacy Data on Medivation's MDV3100 to Be Presented at ASCO-sponsored Prostate Cancer Symposium
Feb 16, 2007
PDF 10.2 KB Add to Briefcase
View Summary Medivation to Present at BIO CEO & Investor Conference 2007
Feb 5, 2007
PDF 10.4 KB Add to Briefcase
View Summary Medivation's Dimebon Phase 2 Trial Results To Be Presented At 8th International Conference On Alzheimer's And Parkinson's Diseases
Jan 30, 2007
PDF 11.2 KB Add to Briefcase
View Summary Medivation Names Lisa Taylor Vice President Of Commercial Development
Jan 17, 2007
PDF 9.7 KB Add to Briefcase
Showing 241-260 of 291 Page: 1 ... 9 10 11 12 13 14 15  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Top